Divisas / MLTX
MLTX: MoonLake Immunotherapeutics - Class A
55.75
USD
0.95
(1.73%)
El tipo de cambio de MLTX de hoy ha cambiado un 1.73%. En este caso, el precio mínimo en el mercado ha alcanzado 53.18, mientras que el máximo ha alcanzado 56.18.
Siga la dinámica de la pareja de divisas MoonLake Immunotherapeutics - Class A. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
MLTX News
- 2 Small-Cap Biotech Stocks Well Positioned for a Breakout
- MoonLake Immunotherapeutics: Maintaining A Small Holding (NASDAQ:MLTX)
- Guggenheim reiterates Buy rating on Moonlake Immunotherapeutics stock
- Merck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery - Merck & Co (NYSE:MRK)
- MoonLake Immunotherapeutics: More Sonelokimab Success, With Big Pharma Interest (MLTX)
- Signet Posts Upbeat Earnings, Joins Ferguson Enterprises, Dollar General And Other Big Stocks Moving Higher On Tuesday - Credo Technology Group (NASDAQ:CRDO), Algonquin Power (NYSE:AQN)
- RBC Capital maintains outperform rating on Moonlake stock
- MoonLake Immunotherapeutics Catapults On Rumored $3 Billion Merck Takeover Bid
- Merck's Dealmaking Intensifies With MoonLake Bid As Keytruda Patent Cliff Nears: Report - MoonLake (NASDAQ:MLTX), Merck & Co (NYSE:MRK)
- Guggenheim reaffirms Buy rating on Moonlake stock amid M&A talks
- Why Credo Technology Group Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Agenus (NASDAQ:AGEN), Bumble (NASDAQ:BMBL)
- Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
- MoonLake Immunotherapeutics stock surges on FT report of Merck buyout talks
- Merck held talks to buy biotech MoonLake for over $3 billion, FT reports
- H.C. Wainwright maintains $100 target on Moonlake stock
- Wolfe Research lifts Moonlake stock to Outperform
- MoonLake Immunotherapeutics: A Buy At Dips (NASDAQ:MLTX)
- This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Bloom Energy (NYSE:BE), Alpha Cognition (NASDAQ:ACOG)
Rango diario
53.18
56.18
Rango anual
31.42
58.26
- Cierres anteriores
- 54.80
- Open
- 54.89
- Bid
- 55.75
- Ask
- 56.05
- Low
- 53.18
- High
- 56.18
- Volumen
- 1.407 K
- Cambio diario
- 1.73%
- Cambio mensual
- 11.37%
- Cambio a 6 meses
- 32.30%
- Cambio anual
- 19.38%
30 agosto, sábado